Navigation Links
Novavax Reports Fourth Quarter and 2008 Year-End Financial Results
Date:3/31/2009

li>
  • The Company took significant measures, including a reduction in force early this year, to reduce its expenses and thereby the yearly burn rate.

  • "We made significant progress in 2008 in advancing our VLP based vaccine pipeline. We demonstrated in Phase II clinical studies that our VLP based flu vaccines are not only well tolerated and immunogenic in humans, but they have the potential to differentiate themselves from currently available alternatives. We also demonstrated that our VLP technology has the potential to create a much needed vaccine against RSV. These advances continue to reinforce that our strategy of using the VLP vaccine platform coupled with our innovative manufacturing solution is working," said Novavax Chief Executive Officer Dr. Rahul Singhvi. "By the second half of 2009, we want to translate these scientific advances into partnerships with private and public entities to leverage capabilities of our partners to accelerate our progress, as we have shown today with the Cadila partnership."

    2008 Financial Results

    Revenue from continuing operations, for the fourth quarter ended December 31, 2008, related to the government contracts was $100,000 compared to $400,000 for the same period in 2007. Revenue for the full year of 2008 was $1.1 million as compared to $1.5 million in 2007. The reduction in our revenue was due to the timing of our completing these contracts.

    Research and development costs for the fourth quarter of 2008 were $5.9 million compared to $4.2 million in the fourth quarter of 2007. For the full year, research and development costs increased 38 percent to $24.3 million in 2008 from $17.6 million in 2007. The increases in both the fourth quarter of 2008 and the year ended December 31, 2008 compared to 2007 were due to higher research and development spending to support the Company's strategic focus on creating d
    '/>"/>

    SOURCE Novavax, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine news :

    1. Novavax Announces Release Date of 2007 Fourth Quarter, Full Year Financial Results and Investor Conference Call
    2. Novavax CEO to Present at the Partnering for Global Health Forum
    3. Novavax CEO to Present at Susquehannas Second SIGnificant Options in Healthcare Conference
    4. Novavax Announces Release Date of 2007 Third Quarter Financial Results and Investor Conference Call
    5. Novavax and Allergan Terminate Manufacturing Supply Agreement for Estrasorb
    6. Novavax CEO to Present at the 2007 UBS Global Life Sciences Conference
    7. Cadus Reports 2008 Results
    8. Nephros Reports 2008 Fourth Quarter and Full Year Financial Results
    9. Cardiogenesis Reports Fourth Quarter and Fiscal Year 2008 Results
    10. Tiens Biotech Group (USA) Reports Record Twelve-Month Results
    11. ULURU Inc. Reports Financial Results for Fourth Quarter and Year Ended December 31, 2008
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/22/2014)... 21, 2014 (HealthDay News) -- Two sisters in high ... damage. Ilina and Medha Krishen use electronic stethoscopes, ... of trouble in breathing patterns or heartbeats. Ilina, ... Michigan, wanted to find a way to detect early ... Using an electronic stethoscope, Ilina recorded one breath cycle ...
    (Date:10/22/2014)... HealthDay Reporter TUESDAY, Oct. 21, 2014 ... fertilization (IVF) -- the incubation of embryos in a laboratory ... the vagina, new research suggests. Scientists from the United ... might sharply cut costs for pricey IVF procedures among certain ... those who don,t live near big-city assisted reproduction centers, the ...
    (Date:10/22/2014)... HealthDay Reporter , MONDAY, Oct. 20, 2014 ... guidelines for health workers treating Ebola patients, now requiring full ... respirator at all times. The U.S. Centers for Disease ... two Dallas nurses contracted Ebola while caring for the first ... Eric Duncan. Nina Pham is currently being treated for her ...
    (Date:10/20/2014)... 2014 The newly updated Worldwide Medical ... thousands of facts, figures and forecasts on the global ... sector forecast categories the Worldwide Medical Market Forecasts ... national views on the worldwide medical market to reveal ... gives you data for 2010-2019, covering each country market ...
    (Date:10/20/2014)... 20, 2014 Allegheny General Hospital’s (AGH) ... enables physicians to repair a damaged mitral valve as ... system, developed by Abbott Vascular , is ... and life-threatening condition in which the heart’s mitral valve ... backward from the heart’s left ventricle into the left ...
    Breaking Medicine News(10 mins):Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4Health News:CDC Tightens Rules on Caring for Ebola Patients 2Health News:CDC Tightens Rules on Caring for Ebola Patients 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 3
    ... of girls and 36.3 percent of boys age 12 to ... of calcium, placing them at serious risk for osteoporosis and ... mass is established by the end of this age range, ... crisis. ,Osteoporosis is a pediatric disease with geriatric ...
    ... feel better, but it won't help them live longer. Patients ... lived an average// of 18 months longer. The 158 women ... the 77 who got only medical treatmen. However, women in ... -- especially if the levels were high to start with. ...
    ... aimed at reducing the risk of damage to normal tissue, ... will enrol 50 children suffering from medulloblastoma – the most ... with lower radiation and increased chemotherapy doses than those currently ... are diagnosed with this curable condition each year. In the ...
    ... tattoos could cause a lifelong allergy to a common chemical ... the trendy tattoos can lead to months of pain and ... the chemical para-phenylene diamine (PPD) which is sometimes added to ... long established practise in India, where it is called mehendi. ...
    ... fossil fuels--especially kerosene, which is sometimes used for heating, ... itching, and other allergy symptoms. Although the exact mechanism ... irritate the nasal lining and set the stage for ... researchers studied the effects of kerosene, gasoline, and electricity ...
    ... low birth weight can significantly improve survival rates, especially ... The research involved 1,154 full-term but smaller than normal ... 1/2 pounds or less. Mothers fed them supplements containing ... 20 who died had not been receiving zinc supplements. ...
    Cached Medicine News:
    (Date:10/22/2014)... YARDLEY, Pa. , Oct. 22, 2014 /PRNewswire/ ... of their animal health medications, a Global Pharmaceutical ... and Antares serialization technology and turnkey solution to ... Photo - http://photos.prnewswire.com/prnh/20141021/153438 ... The product that was serialized and aggregated by ...
    (Date:10/22/2014)... SAN DIEGO , Oct. 21, 2014 /PRNewswire/ ... announced today the latest genomics research centers to ... the Salk Institute, the National Cancer Institute (NCI), ... National Sequencing Center). Before Irys, obtaining a comprehensive ... because next generation sequencing (NGS) does not deliver ...
    (Date:10/22/2014)... 2014 Abaxis, Inc. (NasdaqGS: ABAX ... systems, today reported financial results for the second fiscal ... overview: , Revenues of $53.9 million, up 18% ... of $0.24, up 33% over last year,s comparable quarter. ... Abaxis Veterinary Reference Laboratories (AVRL) of $3.5 million, up ...
    Breaking Medicine Technology:Xyntek and Antares Serialization Solution Protects Pets Too! 2BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 2BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 3Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 2Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 3Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 4Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 5Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 6Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 7Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 8Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 9Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 10Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 11Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 12Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 13Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 14
    ... Laboratories is a national reference laboratory ... organization. ARUP offers an extensive test ... medical tests in clinical and anatomic ... Utah, ARUP Laboratories clients include university ...
    Sharp tipped straight scissors. For cutting in the iris plane or cutting peripheral membranes. May also be useful in ROP cases....
    Disposable Microscissors: Horizontal, Curved...
    Disposable Microscissors: Vertical, 90...
    Medicine Products: